Imagine a tiny, flexible computer made of plastic-like materials that blends into your body instead of using rigid metal chips. It acts like a smart guard that can spot the early signs of a brain storm, like an epileptic seizure, before it happens. Once it detects the danger, it automatically releases the exact amount of medicine needed to stop the attack.
Current bioelectronics use rigid silicon that is incompatible with the soft, ionic nature of the human body. This leads to intrusive implants and inefficient treatment for chronic brain disorders like epilepsy.
A laboratory proof-of-concept for a closed-loop device using organic electrochemical transistors and an iontronic pump for automated drug delivery.
If you are a medical device manufacturer dealing with the 30% of epilepsy patients who are drug-resistant — this project developed a closed-loop neuromorphic circuit that enables local drug delivery at the right time to stop seizures.
If you are a flexible electronics SME dealing with the incompatibility between rigid silicon chips and soft human tissue — this project developed organic electrochemical transistors (OECTs) that are conformable and implantable.
If you are a drug delivery system developer dealing with overmedication side-effects — this project developed an iontronic pump system that administers medication based on real-time signal recognition.
Based on available project data, there is no specific pricing or cost-per-unit information provided.
The project aims to demonstrate a first proof of concept in a laboratory setting, suggesting it is not yet at industrial scale.
Based on available project data, specific IP or licensing terms are not disclosed in the summary.
The project period runs from 2024-05-01 to 2028-04-30, indicating the research phase concludes in 2028.
The project focuses on replacing rigid silicon electronics with soft polymer electronics to better match the human body's ionic flow.
The consortium is heavily academic, consisting of 7 universities and 1 SME across 7 countries. With an industry ratio of only 12%, the project is primarily focused on fundamental research and proof-of-concept development rather than immediate commercialization.
Contact INSTITUT MINES-TELECOM in France
Contact us to track the TRL progression of this organic AI technology.
